Background: Breast cancer is the most common cancer among women worldwide. The disease is quite diverse, with a wide range of prognosis for these patients. Immunohistochemistry with tumor markers is very helpful in finding the prognosis of the disease. In this study, we evaluated the immunohistochemical expression of Epithelial Membrane Antigen (EMA) in breast cancer patients.